Almonty's Korean Listing Ambition Collides With a Slower Sangdong Ramp-Up
Published on 11/22/2026 at 10:51 | Editorial boerse-global.deAlmonty Industries spent mid-November making two very different kinds of news, and the market's verdict arrived on Friday: the stock dropped 16% to €5.82. The decline coincided with a broad selloff on the US equity market that the Associated Press attributed to AI-related shares, though the company's own announcements gave investors plenty to chew on.
At the centre of the story is Sangdong, the tungsten mine whose ramp-up now sits at the heart of every analyst model on the name. Almonty reported third-quarter 2026 revenue of C$41.9 million on 12 November, a jump of 382% year on year, alongside net income of C$50.2 million and adjusted EBITDA of C$14.6 million. The company also confirmed that Sangdong produced its first tungsten concentrate in September, and that more than 90% of Phase I output is already contracted. After the quarter closed, the first container of concentrate was loaded in Busan for shipment overseas.
Analysts Reset the Bar
GBC kept its buy rating on Friday but now expects the Sangdong ramp-up to arrive roughly three quarters later than previously assumed. The resulting cuts are steep: revenue of US$125.9 million for 2026, down from US$365.9 million, and US$520 million for 2027, against a prior forecast of US$1.32 billion.
Should investors sell immediately? Or is it worth buying Almonty?
Diamond Equity Research took a different route to a similar destination, trimming its earnings estimates on 17 November. The firm cut its fiscal 2027 earnings-per-share forecast to US$0.67 from US$1.04, and now models US$0.04 for the fourth quarter of 2026, down from US$0.14. Sphene Capital had already moved on 16 November, following the nine-month figures, lowering its price target to US$22.40 from US$26.40 while reaffirming its buy recommendation.
A Korean Listing and a Boardroom Reshuffle
The same day Diamond published its revisions, Almonty said it intends to pursue a secondary listing on the Korea Exchange, subject to approval from the exchange and the relevant supervisory authorities. Alongside that ambition came governance changes: Eugene Bae and James Rudyk were appointed as independent members of the board, while David Hanick and Andrew Frazer are set to leave the board effective 31 December 2026.
For now, the investment case rests on how quickly Sangdong can convert its contracted order book into steady output. The first cargo has left Busan, the analysts have published their new numbers, and the Korean listing remains a proposal rather than a certainty.
Ad
Almonty Stock: New Analysis - 22 November
Fresh Almonty information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
